ORIC · Oric Pharmaceuticals, Inc. · Insider Trading

$11.98 -0.51 (-4.08%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.36B

103.65M

Volume · Oct 6 251.99K Avg daily vol (3M) 1.49M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-10-01	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.	Common Stock	3,500	$12.91	$45,199	38,300
2026-10-01	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Indirect) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.	Common Stock (I)	3,200	$12.91	$41,325	203,472
2026-10-01	Heyman Richard A.	Director	Convert↑	Common Stock	3,500	$1.60	$5,600	41,800
2026-10-01	Heyman Richard A.	Director	Convert↓ Filing footnotes — Stock Option (right to buy) (Direct) The shares subject to the option are fully vested and immediately exercisable.	Stock Option (right to buy)	3,500	—	—	26,700
2026-09-28	Piscitelli Dominic	Chief Financial Officer	Convert↓	Stock Option (right to buy)	13,400	—	—	78,500
2026-09-28	Piscitelli Dominic	Chief Financial Officer	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026. Represents the weighted average share price of an aggregate total of 13,400 shares sold in the price range of $13.50 to $13.575 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.	Common Stock	13,400	$13.53	$181,258	69,828
2026-09-28	Piscitelli Dominic	Chief Financial Officer	Convert↑	Common Stock	13,400	$4.36	$58,424	83,228
2026-09-24	Piscitelli Dominic	Chief Financial Officer	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.	Common Stock	100	$13.50	$1,350	70,328
2026-09-24	Piscitelli Dominic	Chief Financial Officer	Convert↑	Common Stock	600	$4.36	$2,616	70,428
2026-09-24	Piscitelli Dominic	Chief Financial Officer	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.	Common Stock	500	$13.51	$6,753	69,828
2026-09-24	Piscitelli Dominic	Chief Financial Officer	Convert↓	Stock Option (right to buy)	600	—	—	91,900
2026-08-26	Piscitelli Dominic	Chief Financial Officer	Convert↑ Filing footnotes — Common Stock (Direct) Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.	Common Stock	52,000	$4.36	$226,720	121,828
2026-08-26	Piscitelli Dominic	Chief Financial Officer	Convert↓	Stock Option (right to buy)	52,000	—	—	92,500
2026-08-26	Piscitelli Dominic	Chief Financial Officer	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.	Common Stock	77,000	$13.69	$1,053,814	69,828
2026-08-26	Piscitelli Dominic	Chief Financial Officer	Convert↑	Common Stock	25,000	$6.00	$150,000	146,828
2026-08-26	Piscitelli Dominic	Chief Financial Officer	Convert↓ Filing footnotes — Stock Option (right to buy) (Direct) 25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.	Stock Option (right to buy)	25,000	—	—	120,000
2026-07-24	Heyman Richard A.	Director	Convert↓ Filing footnotes — Stock Option (right to buy) (Direct) The shares subject to the option are fully vested and immediately exercisable.	Stock Option (right to buy)	3,500	—	—	30,200
2026-07-24	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Indirect) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.	Common Stock (I)	6,100	$12.02	$73,322	206,672
2026-07-24	Heyman Richard A.	Director	Convert↑	Common Stock	3,500	$1.60	$5,600	45,300
2026-07-24	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.	Common Stock	7,000	$12.02	$84,140	38,300
2026-07-06	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Indirect) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.	Common Stock (I)	300	$12.00	$3,600	212,772
2026-02-24	Piscitelli Dominic	Chief Financial Officer	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025. Represents the weighted average share price of an aggregate total of 52,000 shares sold in the price range of $13.50 to $13.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.	Common Stock	52,000	$13.51	$702,686	68,148
2026-02-24	Piscitelli Dominic	Chief Financial Officer	Convert↑	Common Stock	52,000	$4.36	$226,720	120,148
2026-02-24	Piscitelli Dominic	Chief Financial Officer	Convert↓	Stock Option (right to buy)	52,000	—	—	144,500
2026-01-16	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Indirect) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.	Common Stock (I)	3,200	$12.00	$38,415	213,072
2026-01-16	Heyman Richard A.	Director	Sell↓ Filing footnotes — Common Stock (Direct) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.	Common Stock	3,500	$12.00	$42,016	41,800
2026-01-02	Heyman Richard A.	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.	Stock Option (right to buy)	40,000	—	—	40,000
2026-01-02	You Angie	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.	Stock Option (right to buy)	40,000	—	—	40,000
2026-01-02	Dier Mardi	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.	Stock Option (right to buy)	40,000	—	—	40,000
2026-01-02	Multani Pratik S	Director	Award↑ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock. 1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028.	Restricted Stock Unit	35,500	—	—	35,500
2026-01-02	Piscitelli Dominic	Chief Financial Officer	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.	Stock Option (right to buy)	206,500	—	—	206,500
2026-01-02	Piscitelli Dominic	Chief Financial Officer	Award↑ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock. 1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028.	Restricted Stock Unit	34,500	—	—	34,500
2026-01-02	Kunkel Lori Anne	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.	Stock Option (right to buy)	40,000	—	—	40,000
2026-01-02	Chacko Jacob	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.	Stock Option (right to buy)	675,000	—	—	675,000
2026-01-02	Multani Pratik S	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.	Stock Option (right to buy)	214,000	—	—	214,000
2026-01-02	Hoerter Steven L.	Director	Award↑ Filing footnotes — Stock Option (right to buy) (Direct) 1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.	Stock Option (right to buy)	40,000	—	—	40,000
2026-01-02	Chacko Jacob	Director	Award↑ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock. 1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028.	Restricted Stock Unit	112,500	—	—	112,500
2025-12-16	Piscitelli Dominic	Chief Financial Officer	Sell↓ Filing footnotes — Common Stock (Direct) Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0396 to $9.1953 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.	Common Stock	10,720	$9.06	$97,127	68,148
2025-12-16	Chacko Jacob	Director	Sell↓ Filing footnotes — Common Stock (Direct) Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. Represents the weighted average share price of an aggregate total of 33,374 shares sold in the price range of $9.0257 to $9.095 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.	Common Stock	33,374	$9.06	$302,368	581,711
2025-12-16	Multani Pratik S	Director	Sell↓ Filing footnotes — Common Stock (Direct) Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0449 to $9.1451 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.	Common Stock	10,720	$9.06	$97,129	68,149
2025-12-15	Chacko Jacob	Director	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026.	Restricted Stock Unit	28,333	—	—	28,334
2025-12-15	Multani Pratik S	Director	Convert↑ Filing footnotes — Common Stock (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. Includes an aggregate of 2,771 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.	Common Stock	29,333	—	—	78,869
2025-12-15	Piscitelli Dominic	Chief Financial Officer	Convert↑ Filing footnotes — Common Stock (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. Includes 1,218 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.	Common Stock	29,333	—	—	78,868
2025-12-15	Chacko Jacob	Director	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025.	Restricted Stock Unit	22,000	—	—	0
2025-12-15	Multani Pratik S	Director	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025.	Restricted Stock Unit	8,000	—	—	0
2025-12-15	Multani Pratik S	Director	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.	Restricted Stock Unit	11,333	—	—	22,667
2025-12-15	Chacko Jacob	Director	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.	Restricted Stock Unit	33,333	—	—	66,667
2025-12-15	Piscitelli Dominic	Chief Financial Officer	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025.	Restricted Stock Unit	8,000	—	—	0
2025-12-15	Multani Pratik S	Director	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026.	Restricted Stock Unit	10,000	—	—	10,000
2025-12-15	Piscitelli Dominic	Chief Financial Officer	Convert↓ Filing footnotes — Restricted Stock Unit (Direct) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026.	Restricted Stock Unit	10,000	—	—	10,000

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 341 transactions

Key facts CIK 1796280 CUSIP 68622P109 13F (30d) 3 filings 3 filers Visit website Investor relations